688166 博瑞醫藥
按盤價 
58.060 -8.350 (-12.573%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.707 | 7.962 | 8.880 | 12.384 | 15.688 |
| 總資產報酬率 ROA (%) | 0.326 | 3.713 | 4.178 | 6.280 | 10.170 |
| 投入資產回報率 ROIC (%) | 0.355 | 4.019 | 4.503 | 6.910 | 11.259 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.708 | 57.510 | 55.794 | 63.011 | 56.227 |
| 營業利潤率 (%) | -0.897 | 12.498 | 16.129 | 23.803 | 24.609 |
| 息稅前利潤/營業總收入 (%) | 2.738 | 15.447 | 18.051 | 24.771 | 25.009 |
| 淨利潤/營業總收入 (%) | 0.308 | 11.014 | 14.703 | 20.783 | 22.573 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 241.051 | 114.473 | 105.522 | 96.612 | 102.124 |
| 價值變動淨收益/利潤總額(%) | 76.515 | -11.026 | -8.084 | 0.232 | 3.892 |
| 營業外收支淨額/利潤總額(%) | 3.965 | -1.965 | -0.781 | 0.021 | -0.597 | 償債能力分析 |
| 流動比率 (X) | 1.334 | 1.559 | 1.995 | 2.388 | 1.703 |
| 速動比率 (X) | 1.013 | 1.212 | 1.621 | 2.043 | 1.360 |
| 資產負債率 (%) | 51.964 | 52.952 | 51.954 | 51.908 | 41.351 |
| 帶息債務/全部投入資本 (%) | 47.091 | 47.184 | 47.836 | 48.341 | 35.207 |
| 股東權益/帶息債務 (%) | 106.093 | 106.877 | 105.609 | 105.323 | 181.201 |
| 股東權益/負債合計 (%) | 88.443 | 87.285 | 90.604 | 90.579 | 136.663 |
| 利息保障倍數 (X) | 0.746 | 4.843 | 8.820 | 25.716 | 45.853 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 99.378 | 85.717 | 89.395 | 119.636 | 94.175 |
| 存貨周轉天數 (天) | 240.629 | 234.266 | 215.752 | 229.802 | 157.568 |
| 備註： | 即時報價更新時間為 26/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
